DCM
XENT

Driehaus Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Driehaus Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-158,600
Closed -$5.94M – 572
2018
Q2 		$5.94M Sell
158,600
-95,038
-37% -$3.73M 0.2% 148
2018
Q1 		$9.97M Buy
253,638
+73,931
+41% +$2.7M 0.35% 66
2017
Q4 		$5.82M Sell
179,707
-15,456
-8% -$463K 0.22% 121
2017
Q3 		$6.08M Sell
195,163
-5,179
-3% -$153K 0.24% 118
2017
Q2 		$5.6M Buy
+200,342
New +$4.54M 0.21% 116
2016
Q2 		– Sell
-66,367
Closed -$1.26M – 675
2016
Q1 		$1.26M Sell
66,367
-37,648
-36% -$682K 0.04% 346
2015
Q4 		$2.34M Sell
104,015
-121,044
-54% -$2.39M 0.08% 266
2015
Q3 		$5.27M Buy
225,059
+166,014
+281% +$4.58M 0.19% 127
2015
Q2 		$1.69M Sell
59,045
-27,369
-32% -$717K 0.06% 359
2015
Q1 		$2.23M Buy
+86,414
New +$1.98M 0.08% 311

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Driehaus Capital Management's XENT Position: Q3 2018 in Review

Driehaus Capital Management sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 158,600 shares — an estimated $5.94M sold.

Driehaus Capital Management first reported a position in XENT in Q1 2015 and held it in 10 quarters. The position peaked at $9.97M in Q1 2018. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Driehaus Capital Management reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Driehaus Capital Management sold 158,600 Intersect ENT, Inc shares in Q3 2018, an estimated $5.94M.
  • Driehaus Capital Management first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 10 quarters.
  • Driehaus Capital Management's Intersect ENT, Inc position peaked at $9.97M in Q1 2018.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Driehaus Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.